annb0t
Top 20
On September 9, 2024, Brett Sandercock, Chief Financial Officer of ResMed Inc (NYSE:RMD), sold 1,000 shares of the company at a price of $246.42 per share. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 96,812 shares of ResMed Inc.
ResMed Inc is a global leader in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, ch...
>>> Read more: Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
ResMed Inc is a global leader in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, ch...
>>> Read more: Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
